These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Treatment of Alzheimer disease with tacrine: a cost-analysis model. Wimo A; Karlsson G; Nordberg A; Winblad B Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):191-200. PubMed ID: 9437436 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of Alzheimer's disease]. Soininen H Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065 [No Abstract] [Full Text] [Related]
26. Tacrine and nursing home placement. Thal LJ; Thomas RG; Sano M Neurology; 1997 Sep; 49(3):897-9. PubMed ID: 9305370 [No Abstract] [Full Text] [Related]
27. The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study". Cutler NR; Sramek JJ Alzheimer Dis Assoc Disord; 1995; 9(3):139-45. PubMed ID: 8534412 [TBL] [Abstract][Full Text] [Related]
29. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
32. [More accurate diagnosis could identify patients suitable for tacrine therapy]. Andreasen N; Eriksson S; Karlsson I; Lindahl B; Lund M; Nordberg A; Wimo A; Winblad B; Astrand R Lakartidningen; 1996 Mar; 93(13):1200. PubMed ID: 8656831 [No Abstract] [Full Text] [Related]
33. Tacrine in Alzheimer's disease. Lachs M N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606 [No Abstract] [Full Text] [Related]
34. Tacrine as a treatment for Alzheimer's dementia: editor's note. An interim report from the FDA. A response from Summers et al. N Engl J Med; 1991 Jan; 324(5):349-52. PubMed ID: 1986300 [No Abstract] [Full Text] [Related]
35. Medical treatment of Alzheimer's disease: past, present, and future. Ott BR Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092 [No Abstract] [Full Text] [Related]